Cargando…
iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery
Non-alcoholic fatty liver disease (NAFLD) affects 30–40% of adults and 10% of children in the US. About 20% of people with NAFLD develop non-alcoholic steatohepatitis (NASH), which may lead to cirrhosis and liver cancer, and is projected to be a leading cause of liver transplantation in the near fut...
Autores principales: | Gurevich, Igor, Burton, Sarah A., Munn, Christie, Ohshima, Makiko, Goedland, Madelyn E., Czysz, Katherine, Rajesh, Deepika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758638/ https://www.ncbi.nlm.nih.gov/pubmed/33268331 http://dx.doi.org/10.1242/bio.055087 |
Ejemplares similares
-
iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
por: Corbett, James L., et al.
Publicado: (2019) -
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019) -
Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells
por: Kiamehr, Mostafa, et al.
Publicado: (2017) -
Bankable human iPSC-derived retinal progenitors represent a valuable source of multipotent cells
por: Gozlan, Sandy, et al.
Publicado: (2023) -
An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes
por: Qiu, Shimeng, et al.
Publicado: (2021)